TheStreet Downgrades Ceridian HCM (NYSE:CDAY) to D+

Ceridian HCM (NYSE:CDAYGet Rating) was downgraded by equities research analysts at TheStreet from a “c-” rating to a “d+” rating in a report issued on Tuesday, TheStreetRatingsTable reports.

A number of other analysts also recently commented on CDAY. Wolfe Research downgraded shares of Ceridian HCM from a “peer perform” rating to an “underperform” rating in a report on Friday, February 11th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Ceridian HCM from $110.00 to $105.00 and set a “buy” rating on the stock in a research note on Thursday, February 10th. Credit Suisse Group initiated coverage on shares of Ceridian HCM in a research note on Wednesday, March 23rd. They set an “outperform” rating and a $85.00 price objective on the stock. Wells Fargo & Company reduced their price objective on shares of Ceridian HCM from $85.00 to $65.00 and set an “equal weight” rating on the stock in a research note on Tuesday, March 15th. Finally, Piper Sandler reduced their price objective on shares of Ceridian HCM from $105.00 to $85.00 and set a “neutral” rating on the stock in a research note on Thursday, February 10th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $96.45.

CDAY stock opened at $56.05 on Tuesday. The company has a market cap of $8.52 billion, a P/E ratio of -112.10 and a beta of 1.47. Ceridian HCM has a 52 week low of $55.92 and a 52 week high of $130.37. The company’s 50-day moving average price is $65.11 and its 200 day moving average price is $89.20. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50.

Ceridian HCM (NYSE:CDAYGet Rating) last released its quarterly earnings data on Wednesday, February 9th. The company reported ($0.14) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.02). The company had revenue of $282.10 million for the quarter, compared to analysts’ expectations of $274.98 million. Ceridian HCM had a negative return on equity of 2.73% and a negative net margin of 7.36%. During the same period in the prior year, the firm posted ($0.02) EPS. On average, equities research analysts expect that Ceridian HCM will post -0.37 earnings per share for the current year.

In other Ceridian HCM news, EVP Christopher R. Armstrong sold 3,891 shares of the stock in a transaction on Wednesday, February 9th. The shares were sold at an average price of $79.48, for a total transaction of $309,256.68. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Christopher R. Armstrong sold 6,861 shares of the stock in a transaction on Wednesday, March 9th. The shares were sold at an average price of $62.49, for a total transaction of $428,743.89. The disclosure for this sale can be found here. Insiders sold 13,353 shares of company stock valued at $900,537 in the last three months. Company insiders own 4.00% of the company’s stock.

Several institutional investors have recently bought and sold shares of the company. Chevy Chase Trust Holdings Inc. lifted its position in shares of Ceridian HCM by 0.7% in the 1st quarter. Chevy Chase Trust Holdings Inc. now owns 82,246 shares of the company’s stock worth $5,622,000 after buying an additional 565 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. increased its holdings in shares of Ceridian HCM by 6.5% in the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 391,509 shares of the company’s stock worth $26,764,000 after acquiring an additional 23,733 shares during the period. Sciencast Management LP acquired a new stake in shares of Ceridian HCM in the 1st quarter worth about $253,000. Calton & Associates Inc. acquired a new stake in shares of Ceridian HCM in the 1st quarter worth about $311,000. Finally, Robeco Institutional Asset Management B.V. acquired a new stake in shares of Ceridian HCM in the 1st quarter worth about $229,000.

Ceridian HCM Company Profile (Get Rating)

Ceridian HCM Holding Inc, together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market.

Featured Stories

Analyst Recommendations for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.